COLPAL - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.3
| Stock Code | COLPAL | Market Cap | 58,681 Cr. | Current Price | 2,157 ₹ | High / Low | 2,519 ₹ |
| Stock P/E | 44.0 | Book Value | 58.2 ₹ | Dividend Yield | 2.36 % | ROCE | 105 % |
| ROE | 81.2 % | Face Value | 1.00 ₹ | DMA 50 | 2,099 ₹ | DMA 200 | 2,187 ₹ |
| Chg in FII Hold | -1.58 % | Chg in DII Hold | 1.75 % | PAT Qtr | 330 Cr. | PAT Prev Qtr | 328 Cr. |
| RSI | 55.6 | MACD | 31.4 | Volume | 2,08,989 | Avg Vol 1Wk | 2,96,890 |
| Low price | 1,782 ₹ | High price | 2,519 ₹ | PEG Ratio | 4.39 | Debt to equity | 0.04 |
| 52w Index | 50.9 % | Qtr Profit Var | 2.25 % | EPS | 48.8 ₹ | Industry PE | 44.2 |
📊 Financials: COLPAL has a market cap of 58,681 Cr. with quarterly PAT at 330 Cr., nearly flat compared to 328 Cr. (+2.25%). ROE at 81.2% and ROCE at 105% are exceptionally strong, reflecting outstanding efficiency and profitability. Debt-to-equity at 0.04 highlights a near debt-free balance sheet. EPS of 48.8 ₹ supports earnings visibility, with stable cash flows.
💹 Valuation: The stock trades at a P/E of 44.0, in line with the industry average of 44.2, suggesting fair valuation. P/B ratio is ~37.0 (2157/58.2), reflecting premium pricing. PEG ratio of 4.39 indicates growth is already priced in. Intrinsic value appears close to current price, offering limited margin of safety but strong income potential.
🏢 Business Model: COLPAL operates in consumer goods, primarily oral care, benefiting from strong brand recognition and market leadership. Its competitive advantage lies in brand loyalty, distribution strength, and consistent demand. Profitability metrics underline resilience, though growth remains modest.
📈 Entry Zone: With RSI at 55.6 (neutral), MACD positive, and price near DMA 50 (2099 ₹) and DMA 200 (2187 ₹), accumulation around 2,100–2,150 ₹ looks favorable. Long-term holding is justified given strong fundamentals, high ROE/ROCE, and dividend yield, though investors should monitor valuation premiums.
Positive
- 📌 Exceptional ROE of 81.2% and ROCE of 105%.
- 📌 Debt-to-equity of 0.04 indicates near debt-free status.
- 📌 EPS of 48.8 ₹ supports earnings visibility.
- 📌 Dividend yield of 2.36% adds income appeal.
- 📌 Increase in DII holdings (+1.75%) shows domestic institutional confidence.
Limitation
- ⚠️ P/B ratio of ~37.0 indicates expensive valuation relative to book value.
- ⚠️ PEG ratio of 4.39 suggests growth is fully priced in.
- ⚠️ PAT growth remains modest (+2.25%).
Company Negative News
- ❌ Decline in FII holdings (-1.58%) indicates reduced foreign investor confidence.
Company Positive News
- ✅ Increase in DII holdings (+1.75%) shows strong domestic support.
- ✅ Stable quarterly profits and strong dividend yield.
Industry
- 🏦 FMCG sector benefits from consistent demand and brand loyalty.
- 🏦 Industry P/E at 44.2 suggests COLPAL trades at fair value.
Conclusion
🔑 COLPAL is fundamentally strong with exceptional return metrics, debt-free operations, and strong brand presence. Despite premium valuations and modest growth, entry around 2,100–2,150 ₹ offers a good balance for long-term investors seeking stability and dividend income. The company remains a resilient leader in the FMCG sector with strong fundamentals and consumer trust.
For deeper insights, you could explore a peer comparison or an FMCG sector outlook to see how COLPAL stacks up against competitors.